I propose to answer Questions Nos. 563 and 564 together.
Ireland along with the other member states of the EC maintains its own independent licensing system for medicinal products. These take account of, and reflect, the provisions of Community directives on the licensing of medicines and I do not accept that Irish regulations are contrary to the spirit of the Treaty of Rome.
The requirements regarding the licensing of medicines are set out in the Medical Preparations (Licensing, Advertisement and Sale) Regulations 1984-1989. The procedures followed are the same for all medicines and in the interests of protecting public health, I would not wish to introduce lesser standards of scrutiny for particular categories of medicines.
I do not accept that the costs of licensing fees in respect of medicines are reducing the range of natural or herbal medicines available in this country. The licence fees are set at the level necessary to meet the costs incurred by the State in assessing and evaluating applications for licences.
The current licence fee in respect of a product authorisation is £1,605 for a period of five years. This is equivalent to an annualised fee of £321 per product authorisation.
The following is a schedule of fees currently payable in respect of the licensing of medicines. There is no distinction made between different categories of medicines, such as natural or herbal, nor are there separate scales of fees depending on whether an applicant for a product authorisation is a manufacturer, wholesaler or retailer.